Overall rank by patents
#611
Across all tracked assignees
USPTO PatentsView assignee record - 723 granted patents across 75 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H10H (INORGANIC LIGHT-EMITTING SEMICONDUCTOR DEVICES HAVING POTENTIAL BARRIERS).
The verdict
Seoul holds 723 US patents across 75 technology areas, rank #611 of 50,000 tracked assignees.
Seoul Viosys Co., Ltd. has been granted 723 US utility patents between 2015 and 2025, placing Seoul Viosys Co., Ltd. at rank #611 across all assignees tracked by PlainPatent. This portfolio spans 75 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.7 claims per patent with primary concentration in H10H (INORGANIC LIGHT-EMITTING SEMICONDUCTOR DEVICES HAVING POTENTIAL BARRIERS). As a Foreign Corporation, Seoul Viosys Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Seoul sits between SMC Corporation (728 patents, rank #607) and Roku, Inc. (717 patents, rank #615) - the closest US assignees by grant volume. The composite Innovation Score of 69.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 410 grants, compared with 313 in the 2015–2019 window, a +31% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Seoul Viosys Co., Ltd.'s 18.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 75 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Seoul Viosys Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SMC CORPORATION
728 patents
TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD.
728 patents
ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.
727 patents
EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
724 patents
SEOUL VIOSYS CO., LTD.
723 patents
Sanofi
721 patents
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
720 patents
HOYA CORPORATION
718 patents
Roku, Inc.
717 patents
What this shows Seoul holds 723 patents at rank #611, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #611 in granted patent volume.
Other assignees with the most granted patents in Seoul's primary technology class.
Seoul's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
70 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 60 | 8.3% |
| 2016 | 77 | 10.7% |
| 2017 | 52 | 7.2% |
| 2018 | 58 | 8.0% |
| 2019 | 66 | 9.1% |
| 2020 | 52 | 7.2% |
| 2021 | 43 | 5.9% |
| 2022 | 81 | 11.2% |
| 2023 | 84 | 11.6% |
| 2024 | 96 | 13.3% |
| 2025 | 54 | 7.5% |
Top 15 of 75 technology areas
Overall rank by patents
#611
Across all tracked assignees
69.8 out of 100
How to use this portfolio
Seoul's 723 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.